ANDA 212898, held by Teva Pharms USA Inc. Chlorzoxazone.
As of Nov 15, 2026, ANDA 212898 (Chlorzoxazone), held by Teva Pharms USA Inc, was first approved by FDA on Jun 17, 2020, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jun 17, 2020 | Original application | Approved | None posted |
| Chlorzoxazone375MG · tablet;oral | Chlorzoxazone | Discontinued |
| Chlorzoxazone750MG · tablet;oral | Chlorzoxazone | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters
